DUBLIN--(BUSINESS WIRE)--The "Biopreservation Market Size, Share & Trends Analysis Report By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Provider, And Segment Forecasts, 2012 - 2022" report has been added to ResearchAndMarkets.com's offering.
Key Findings
- In 2014, equipment captured the dominant share by product owing to growing demand from bio-banks. High preservation costs of biological specimens has also benefited this segment.
- The media segment, on the other hand, is predicted to witness exponential CAGR during the coming years as a result of wide adoption in regenerative medicine.
- In 2014, bio-banking captured a substantial share in terms of application owing to growing number of tissue and organ transplantations and high awareness levels with respect to bio-banking.
- Regenerative medicine, on the other hand, is anticipated to register the highest CAGR owing to major investments by public and private healthcare organizations in research focused on restorative therapy.
- By cell provider, tumor cells captured the largest share in terms of volume in 2014, as a consequence of extensive application in R&D and treatment of cancers with high prevalence.
Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Bio-preservation Industry Outlook
Chapter 4. Bio-preservation Product Outlook
Chapter 5. Bio-Preservation Application Outlook
Chapter 6. Bio-Preservation Cell Providers Outlook
Chapter 7. Bio-preservation Regional Outlook
Chapter 8. Competitive Landscape
- BioCision, LLC
- Biomatrica, Inc.
- BioLife Solutions, Inc.
- Chart MVE Biomedical
- LabVantage Solutions, Inc.
- Atlanta Biologics Inc.
- Taylor-Wharton Cryogenics LLC
- Panasonic Corporation
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- VWR International, LLC
- BIOGENICS
For more information about this report visit https://www.researchandmarkets.com/research/74xchg/the?w=4